F
c-Engineered Antibody Expression Vectors with enhanced Fc-effector function are now available in store. These include human IgG1 and IgG4 heavy chains with increased or decreased ADCC and CDC, an aglycosylated human IgG1 heavy chain variant, and a human IgG1 with extended serum half-life.